PALM3 and hearing loss: a potential dual diagnosis interfering with novel gene discovery

This study identifies a homozygous splice-site variant in PALM3 as a likely cause of autosomal recessive non-syndromic hearing loss in a consanguineous family, supported by functional evidence of loss of function and mouse model data, while highlighting the challenge of distinguishing this novel gene from a concurrent OTOA variant in dual molecular diagnoses.

The Gist

The Big Picture: A Mystery in the Family Tree

Imagine your hearing is like a high-end stereo system. For the music to play perfectly, thousands of tiny parts need to work together. Sometimes, the stereo breaks because of a single broken wire (a genetic mutation). Usually, scientists can trace the broken wire to one specific part.

But in this study, researchers found a family where the stereo might be broken by two different problems at once. This makes it very hard to figure out which part is actually causing the silence.

The family is from Iran, and they have a history of relatives marrying relatives (consanguinity). This often means that "broken instructions" (genetic variants) get passed down and end up in pairs, which is usually when they cause disease.

The Two Suspects: PALM3 and OTOA

The scientists looked at the DNA of the main patient (the "proband") and found two suspicious clues:

1. Suspect A (OTOA): This is a known "bad actor." We already know that if this gene is broken, it causes deafness. The patient has two broken copies of this gene.
2. Suspect B (PALM3): This is a new, unknown suspect. The patient also has two broken copies of this gene. Until now, we didn't know for sure if breaking this gene caused deafness in humans, though mouse experiments suggested it might.

The Dilemma: Is the patient deaf because of Suspect A? Or Suspect B? Or both? It's like a car that won't start because the battery is dead and the spark plugs are missing. You can't be 100% sure which one is the main culprit without testing.

The Investigation: How They Caught the Culprit

To solve the mystery, the scientists used three different detective tools:

1. The "Minigene" Test (The Paper Prototype)

The mutation in the PALM3 gene was a "splice-site" error. Think of a gene like a movie script. To make the final movie (the protein), the editor has to cut out the boring parts (introns) and stitch the good scenes (exons) together.

• The Problem: The mutation was like a typo in the editor's instructions, telling them to skip a whole scene.
• The Test: The scientists built a tiny, artificial version of this gene in a lab (a minigene) and watched how it was edited.
• The Result: The editor skipped the scene entirely! This caused the rest of the script to get jumbled up, resulting in a protein that was either too short or completely useless. This confirmed that PALM3 is indeed broken in a way that stops it from working.

2. The Mouse Model (The Animal Proof)

Scientists have previously created mice with the PALM3 gene completely turned off (a "knockout").

• The Result: These mice went deaf. Their inner ear cells (the tiny hairs that catch sound) fell apart because the "scaffolding" holding them together collapsed.
• The Human Connection: Since turning off the gene in mice causes deafness, it is highly likely that breaking the gene in humans does the same thing.

3. The "Half-Broken" Test (The Aging Check)

The researchers also looked at mice that had only one broken copy of the gene (heterozygous). These mice are like humans who carry one bad gene but don't get sick yet.

• The Test: They checked the ears of these mice when they were 12 months old (old for a mouse).
• The Result: The mice with one broken gene still had healthy ears. This suggests that having just one bad copy isn't enough to cause hearing loss; you need both copies broken to lose your hearing. This supports the idea that the patient's deafness is caused by having two broken copies of PALM3.

The Verdict: A "Dual Diagnosis"

The paper concludes that this patient likely has a dual diagnosis.

• They have a confirmed broken gene (OTOA) that causes deafness.
• They also have a newly discovered broken gene (PALM3) that likely causes deafness on its own.

It's possible that having both broken genes made their hearing loss worse or started earlier than if they only had one.

Why This Matters

1. New Discovery: This study provides the first strong evidence that PALM3 is a human deafness gene. It's like finding a new piece of the puzzle that explains why some families have hearing loss that we couldn't explain before.
2. The "Dual" Problem: It highlights that sometimes, patients have more than one genetic problem. If doctors only look for one, they might miss the second one, which could be important for understanding the disease or future treatments.
3. Age-Related Hearing: The study suggests that genes involved in severe, early deafness might also play a role in the slow hearing loss we get as we get older (like losing the bass in your stereo as you age).

The Takeaway

Think of the human ear as a complex machine. This paper found a new part (PALM3) that is essential for keeping that machine running. When that part breaks, the machine stops. In this specific family, the machine was broken by two different parts failing at the same time, making the diagnosis a tricky puzzle that the scientists finally solved using lab tests and mouse models.

Technical Summary

1. Problem Statement

Hereditary hearing loss is characterized by extreme genetic heterogeneity, with over 155 genes linked to early-onset non-syndromic hearing loss and approximately 80 candidate genes for age-related hearing loss (ARHL). A significant challenge in genetic diagnostics is the "dual diagnosis" scenario, where a patient harbors pathogenic variants in two different genes, complicating the identification of the primary causative factor. Furthermore, many genes implicated in ARHL overlap with Mendelian deafness genes, yet their specific roles in rare, biallelic loss-of-function (LOF) scenarios remain uncharacterized. This study addresses the difficulty of distinguishing causative variants in consanguineous families and investigates the potential of PALM3 as a novel human deafness gene.

2. Methodology

The study employed a multi-disciplinary approach combining clinical genetics, bioinformatics, functional assays, and comparative animal models:

• Cohort & Clinical Assessment: The researchers analyzed an extended consanguineous family with autosomal recessive (AR) non-syndromic hearing loss. The proband and spouse underwent comprehensive otologic evaluations, including pure-tone audiometry to determine hearing thresholds and severity.
• Genomic Sequencing & Bioinformatics: Whole-exome sequencing (WES) was performed on the proband and spouse. Variants were filtered based on rarity (MAF < 0.01), inheritance patterns (homozygous in proband), and predicted pathogenicity using in silico tools (SIFT, PolyPhen-2, REVEL, CADD, SpliceAI). Variants were classified according to ACMG/AMP guidelines adapted for hearing loss.
• Functional Validation (Minigene Assay): To determine the effect of the PALM3 splice-site variant (c.314+1G>A), a minigene assay was constructed. The region containing exons 4 and 5 was cloned into a pSPL3 vector and transfected into HEK293T cells. RT-PCR and gel electrophoresis were used to visualize splicing patterns.
• Animal Model Analysis: The study utilized Palm3 heterozygous mice (12 months old) to assess the impact of reduced gene dosage on age-related hair cell loss. Cochlear tissues were processed for immunohistochemistry (staining for Myosin7A and nuclei) and confocal microscopy to quantify inner (IHC) and outer (OHC) hair cell counts and morphology.

3. Key Results

• Genetic Findings:

  • The proband was found to harbor two homozygous variants:
    1. PALM3: c.314+1G>A (NM_001145028.2), a splice-site variant.
    2. OTOA: c.1939G>C, p.(Gly647Arg) (DFNB22), a missense variant previously classified as a Variant of Uncertain Significance (VUS) or pathogenic in other contexts.
  • The spouse carried a homozygous TMC1 variant (c.1535G>A), suggesting a potential dual molecular diagnosis within the couple, though the proband's phenotype is the primary focus.
  • Segregation analysis confirmed the proband is homozygous for both PALM3 and OTOA, while the affected parent is heterozygous for PALM3 and homozygous for OTOA.

• Functional Characterization of PALM3:

  • Splicing Analysis: The PALM3 c.314+1G>A variant abolishes the native splice donor site. The minigene assay demonstrated aberrant splicing resulting in two distinct outcomes:
    1. Exon 4 skipping: Causes a frameshift (p.Arg58ThrfsTer47).
    2. Exons 4–5 skipping: Causes an in-frame deletion (p.Arg58_Gln133del), removing 75 amino acids.
  • Both outcomes are predicted to result in a loss of function (LOF) across all known PALM3 transcripts.

• Phenotypic Concordance:

  • Mouse Model: While Palm3 knockout (KO) mice exhibit early-onset progressive hearing loss and structural disorganization, the heterozygous Palm3 mice (12 months old) showed preserved cochlear architecture and normal hair cell counts compared to wild-type controls. This suggests that partial gene dosage (heterozygosity) does not significantly accelerate age-related hair cell loss in mice, supporting a recessive LOF mechanism in humans.

4. Key Contributions

• Novel Gene Discovery: This study provides the first evidence linking biallelic PALM3 loss-of-function variants to human autosomal recessive non-syndromic hearing loss. It supports the candidacy of PALM3 for future designation as a deafness gene (DFNB).
• Dual Diagnosis Illustration: The case highlights the complexity of genetic diagnostics where a patient may carry pathogenic variants in two distinct genes (PALM3 and OTOA). The study demonstrates how re-analysis of WES data can uncover rare LOF variants that were initially overshadowed by known deafness genes.
• Mechanistic Insight: The research confirms that PALM3 disruption leads to aberrant splicing and protein truncation, aligning with the known function of Paralemmins in membrane and cytoskeletal stability in hair cells.
• Bridge Between ARHL and Mendelian Deafness: By connecting a gene associated with age-related hearing susceptibility (via GWAS) to a rare Mendelian form of deafness, the study reinforces the genetic overlap between early-onset and late-onset hearing loss.

5. Significance

• Clinical Implications: The findings underscore the necessity of rigorous variant interpretation in consanguineous families, where multiple homozygous loci may coexist. Identifying PALM3 as a causative gene expands the diagnostic panel for hereditary hearing loss.
• Therapeutic Potential: Understanding that PALM3 is essential for hair cell membrane resilience suggests it could be a target for gene therapy or pharmacological interventions, particularly given that Palm3 delivery partially restored function in mouse models in previous studies.
• Research Direction: The study emphasizes the importance of investigating VUS in known deafness genes and rare variants in genes associated with complex traits (like ARHL) to fully elucidate the genetic architecture of hearing loss.

In conclusion, this paper successfully identifies PALM3 as a novel candidate gene for autosomal recessive hearing loss, validated through functional splicing assays and supported by comparative mouse model data, while illustrating the challenges and importance of resolving dual molecular diagnoses in complex genetic cases.